• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Grants
    • Partners
    • NCSG Bylaws
JOIN NOW
✕
Categories
  • Primary Biliary Cholangitis
Tags

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

 

Study title Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
Disease or condition Primary Biliary Cholangitis
Study type Interventional (clinical trial)
Intervention/treatment Seladelpar (capsule)
Phase 3
Study site Duke University
Study location Durham, NC
Principal investigator name Andrew Muir, MD
Study coordinator name and email Christy Walters, RN christy.walters@duke.edu
Phone contact 919-668-5499
Clinicaltrials.gov link https://www.clinicaltrials.gov/ct2/show/NCT03301506

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN NOW